Feasibility of a heart failure disease management program in Eastern Europe: Tbilisi, Georgia

Kathy Hebert, Henry C. Quevedo, Ilia Gogichaishvili, Nino Nozadze, Ekaterine Sagirashvili, Patrick Trahan, Nicholas Kipshidze, Lee M. Arcement

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background - Little is known about the importation of a heart failure disease management program (HFDMP) into lowand middle-income countries. We examined the feasibility of importing a HFDMP into the country of Georgia, located in the Caucuses. Methods and Results - Patients with ejection fraction ≥40% were enrolled into a prospective, observational study consisting of a new HFDMP staffed by local cardiologists. Medications, emergency department use, hospital admissions, and mortality were assessed by interviews with patients or their families. Screening resulted in 400 patients who were followed for 10.2±3.5 months. β-Blocker prescriptions increased from 7.4-80.7% (P<0.001), angiotensinconverting enzyme inhibitor prescriptions increased from 18.4-92.6% (P<0.001), and mean systolic blood pressure declined from 145 to 114 mm Hg (P<0.001). Patients visiting the emergency department and hospitalizations were lowered by 40.7% and 52.5%, respectively, but were also influenced by the outbreak of war, during which 17.5% (n=70) of patients received follow-up in refugee tents. All-cause mortality extended to 7% of patients, with 12 of 28 deaths caused by war-related events. Conclusions - Importation of a Western HFDMP was demonstrated to be feasible, with a 5-fold increase in the use of recommended therapies, reduction of blood pressure, decrease of emergency department visits, and hospitalizations for heart failure. These measures could result in substantial cost savings in resource-limited settings, but assessment is complicated in unstable areas. Translating effective interventions to low- and middle-income countries requires sensitivity to regional cultures and flexibility to adapt both clinical goals and strategies to unexpected conditions.

Original languageEnglish
Pages (from-to)763-769
Number of pages7
JournalCirculation: Heart Failure
Volume4
Issue number6
DOIs
StatePublished - Nov 1 2011
Externally publishedYes

Fingerprint

Eastern Europe
Disease Management
Heart Diseases
Heart Failure
Hospital Emergency Service
Blood Pressure
Prescriptions
Hospitalization
Refugees
Cost Savings
Enzyme Inhibitors
Hospital Mortality
Observational Studies
Disease Outbreaks
Prospective Studies
Interviews
Mortality

Keywords

  • Compliance/adherence
  • Ethics and policy
  • Health policy
  • Medication adherence
  • Outcome assessment
  • Treatment

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Medicine(all)

Cite this

Hebert, K., Quevedo, H. C., Gogichaishvili, I., Nozadze, N., Sagirashvili, E., Trahan, P., ... Arcement, L. M. (2011). Feasibility of a heart failure disease management program in Eastern Europe: Tbilisi, Georgia. Circulation: Heart Failure, 4(6), 763-769. https://doi.org/10.1161/CIRCHEARTFAILURE.111.962431

Feasibility of a heart failure disease management program in Eastern Europe : Tbilisi, Georgia. / Hebert, Kathy; Quevedo, Henry C.; Gogichaishvili, Ilia; Nozadze, Nino; Sagirashvili, Ekaterine; Trahan, Patrick; Kipshidze, Nicholas; Arcement, Lee M.

In: Circulation: Heart Failure, Vol. 4, No. 6, 01.11.2011, p. 763-769.

Research output: Contribution to journalArticle

Hebert, K, Quevedo, HC, Gogichaishvili, I, Nozadze, N, Sagirashvili, E, Trahan, P, Kipshidze, N & Arcement, LM 2011, 'Feasibility of a heart failure disease management program in Eastern Europe: Tbilisi, Georgia', Circulation: Heart Failure, vol. 4, no. 6, pp. 763-769. https://doi.org/10.1161/CIRCHEARTFAILURE.111.962431
Hebert, Kathy ; Quevedo, Henry C. ; Gogichaishvili, Ilia ; Nozadze, Nino ; Sagirashvili, Ekaterine ; Trahan, Patrick ; Kipshidze, Nicholas ; Arcement, Lee M. / Feasibility of a heart failure disease management program in Eastern Europe : Tbilisi, Georgia. In: Circulation: Heart Failure. 2011 ; Vol. 4, No. 6. pp. 763-769.
@article{c69b6704255e4a229e7dec1589062467,
title = "Feasibility of a heart failure disease management program in Eastern Europe: Tbilisi, Georgia",
abstract = "Background - Little is known about the importation of a heart failure disease management program (HFDMP) into lowand middle-income countries. We examined the feasibility of importing a HFDMP into the country of Georgia, located in the Caucuses. Methods and Results - Patients with ejection fraction ≥40{\%} were enrolled into a prospective, observational study consisting of a new HFDMP staffed by local cardiologists. Medications, emergency department use, hospital admissions, and mortality were assessed by interviews with patients or their families. Screening resulted in 400 patients who were followed for 10.2±3.5 months. β-Blocker prescriptions increased from 7.4-80.7{\%} (P<0.001), angiotensinconverting enzyme inhibitor prescriptions increased from 18.4-92.6{\%} (P<0.001), and mean systolic blood pressure declined from 145 to 114 mm Hg (P<0.001). Patients visiting the emergency department and hospitalizations were lowered by 40.7{\%} and 52.5{\%}, respectively, but were also influenced by the outbreak of war, during which 17.5{\%} (n=70) of patients received follow-up in refugee tents. All-cause mortality extended to 7{\%} of patients, with 12 of 28 deaths caused by war-related events. Conclusions - Importation of a Western HFDMP was demonstrated to be feasible, with a 5-fold increase in the use of recommended therapies, reduction of blood pressure, decrease of emergency department visits, and hospitalizations for heart failure. These measures could result in substantial cost savings in resource-limited settings, but assessment is complicated in unstable areas. Translating effective interventions to low- and middle-income countries requires sensitivity to regional cultures and flexibility to adapt both clinical goals and strategies to unexpected conditions.",
keywords = "Compliance/adherence, Ethics and policy, Health policy, Medication adherence, Outcome assessment, Treatment",
author = "Kathy Hebert and Quevedo, {Henry C.} and Ilia Gogichaishvili and Nino Nozadze and Ekaterine Sagirashvili and Patrick Trahan and Nicholas Kipshidze and Arcement, {Lee M.}",
year = "2011",
month = "11",
day = "1",
doi = "10.1161/CIRCHEARTFAILURE.111.962431",
language = "English",
volume = "4",
pages = "763--769",
journal = "Circulation. Heart failure",
issn = "1941-3297",
publisher = "Lippincott Williams and Wilkins",
number = "6",

}

TY - JOUR

T1 - Feasibility of a heart failure disease management program in Eastern Europe

T2 - Tbilisi, Georgia

AU - Hebert, Kathy

AU - Quevedo, Henry C.

AU - Gogichaishvili, Ilia

AU - Nozadze, Nino

AU - Sagirashvili, Ekaterine

AU - Trahan, Patrick

AU - Kipshidze, Nicholas

AU - Arcement, Lee M.

PY - 2011/11/1

Y1 - 2011/11/1

N2 - Background - Little is known about the importation of a heart failure disease management program (HFDMP) into lowand middle-income countries. We examined the feasibility of importing a HFDMP into the country of Georgia, located in the Caucuses. Methods and Results - Patients with ejection fraction ≥40% were enrolled into a prospective, observational study consisting of a new HFDMP staffed by local cardiologists. Medications, emergency department use, hospital admissions, and mortality were assessed by interviews with patients or their families. Screening resulted in 400 patients who were followed for 10.2±3.5 months. β-Blocker prescriptions increased from 7.4-80.7% (P<0.001), angiotensinconverting enzyme inhibitor prescriptions increased from 18.4-92.6% (P<0.001), and mean systolic blood pressure declined from 145 to 114 mm Hg (P<0.001). Patients visiting the emergency department and hospitalizations were lowered by 40.7% and 52.5%, respectively, but were also influenced by the outbreak of war, during which 17.5% (n=70) of patients received follow-up in refugee tents. All-cause mortality extended to 7% of patients, with 12 of 28 deaths caused by war-related events. Conclusions - Importation of a Western HFDMP was demonstrated to be feasible, with a 5-fold increase in the use of recommended therapies, reduction of blood pressure, decrease of emergency department visits, and hospitalizations for heart failure. These measures could result in substantial cost savings in resource-limited settings, but assessment is complicated in unstable areas. Translating effective interventions to low- and middle-income countries requires sensitivity to regional cultures and flexibility to adapt both clinical goals and strategies to unexpected conditions.

AB - Background - Little is known about the importation of a heart failure disease management program (HFDMP) into lowand middle-income countries. We examined the feasibility of importing a HFDMP into the country of Georgia, located in the Caucuses. Methods and Results - Patients with ejection fraction ≥40% were enrolled into a prospective, observational study consisting of a new HFDMP staffed by local cardiologists. Medications, emergency department use, hospital admissions, and mortality were assessed by interviews with patients or their families. Screening resulted in 400 patients who were followed for 10.2±3.5 months. β-Blocker prescriptions increased from 7.4-80.7% (P<0.001), angiotensinconverting enzyme inhibitor prescriptions increased from 18.4-92.6% (P<0.001), and mean systolic blood pressure declined from 145 to 114 mm Hg (P<0.001). Patients visiting the emergency department and hospitalizations were lowered by 40.7% and 52.5%, respectively, but were also influenced by the outbreak of war, during which 17.5% (n=70) of patients received follow-up in refugee tents. All-cause mortality extended to 7% of patients, with 12 of 28 deaths caused by war-related events. Conclusions - Importation of a Western HFDMP was demonstrated to be feasible, with a 5-fold increase in the use of recommended therapies, reduction of blood pressure, decrease of emergency department visits, and hospitalizations for heart failure. These measures could result in substantial cost savings in resource-limited settings, but assessment is complicated in unstable areas. Translating effective interventions to low- and middle-income countries requires sensitivity to regional cultures and flexibility to adapt both clinical goals and strategies to unexpected conditions.

KW - Compliance/adherence

KW - Ethics and policy

KW - Health policy

KW - Medication adherence

KW - Outcome assessment

KW - Treatment

UR - http://www.scopus.com/inward/record.url?scp=84855609811&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84855609811&partnerID=8YFLogxK

U2 - 10.1161/CIRCHEARTFAILURE.111.962431

DO - 10.1161/CIRCHEARTFAILURE.111.962431

M3 - Article

C2 - 21900187

AN - SCOPUS:84855609811

VL - 4

SP - 763

EP - 769

JO - Circulation. Heart failure

JF - Circulation. Heart failure

SN - 1941-3297

IS - 6

ER -